Kiora Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Kiora Pharmaceuticals is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -2.33 Dollars per share in 2023, which was 62.59 higher than 2021. And about -2.0E-5 billion Dollars are reported as free cash flow in the financials of Kiora Pharmaceuticals 2023. No dividends were paid to the shareholders of the Kiora Pharmaceuticals stock NasdaqCM:KPRX in the financial year 2023.

$0.00M

Revenue

$-16.61

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-16.61

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.01M	$2.69M	$1.65M	$0.41M	$0.67M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	-82.03%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	-,246.06%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-4.00	$-16.61	$-44.40	$-70.80	$-89.20	$-,180.00	$-,558.00	$-,906.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	1.92M	0.33M	0.18M	0.12M	0.07M	0.03M	0.02M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$-8.41M
FCF	Free Cash Flow	N/A	$0.00M	$-10.95M	$0.00M	$0.00M	$0.00M	$0.00M	$-8.42M
FCFS	Free Cash Flow Per Share	$-2.75	$-14.24	$-1.11	$-1.60	$-2.56	$-4.70	$-6.84	$-14.30

Kiora Pharmaceuticals financials at a glance

Financials

Discover